545 related articles for article (PubMed ID: 26439665)
1. Non-viral therapeutic approaches to ocular diseases: An overview and future directions.
Zulliger R; Conley SM; Naash MI
J Control Release; 2015 Dec; 219():471-487. PubMed ID: 26439665
[TBL] [Abstract][Full Text] [Related]
2. Treatment of ocular disorders by gene therapy.
Solinís MÁ; del Pozo-Rodríguez A; Apaolaza PS; Rodríguez-Gascón A
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):331-42. PubMed ID: 25536112
[TBL] [Abstract][Full Text] [Related]
3. The Ocular Gene Delivery Landscape.
Sahu B; Chug I; Khanna H
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439800
[TBL] [Abstract][Full Text] [Related]
4. [Developments in gene delivery vectors for ocular gene therapy].
Khabou H; Dalkara D
Med Sci (Paris); 2015 May; 31(5):529-37. PubMed ID: 26059304
[TBL] [Abstract][Full Text] [Related]
5. A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium.
Koirala A; Conley SM; Naash MI
Biomaterials; 2013 Sep; 34(29):7158-67. PubMed ID: 23796578
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy progress and prospects: the eye.
Bainbridge JW; Tan MH; Ali RR
Gene Ther; 2006 Aug; 13(16):1191-7. PubMed ID: 16838031
[TBL] [Abstract][Full Text] [Related]
7. Minicircle Delivery to the Neural Retina as a Gene Therapy Approach.
Staurenghi F; McClements ME; Salman A; MacLaren RE
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232975
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-based technologies for retinal gene therapy.
Adijanto J; Naash MI
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):353-67. PubMed ID: 25592325
[TBL] [Abstract][Full Text] [Related]
9. Adeno-Associated Viral Vectors as a Tool for Large Gene Delivery to the Retina.
Trapani I
Genes (Basel); 2019 Apr; 10(4):. PubMed ID: 30970639
[TBL] [Abstract][Full Text] [Related]
10. Nuclear targeting of viral and non-viral DNA.
Chowdhury EH
Expert Opin Drug Deliv; 2009 Jul; 6(7):697-703. PubMed ID: 19552613
[TBL] [Abstract][Full Text] [Related]
11. Ocular gene therapy: current progress and future prospects.
Colella P; Cotugno G; Auricchio A
Trends Mol Med; 2009 Jan; 15(1):23-31. PubMed ID: 19097940
[TBL] [Abstract][Full Text] [Related]
12. Suprachoroidal Delivery of Viral and Nonviral Gene Therapy for Retinal Diseases.
Kansara V; Muya L; Wan CR; Ciulla TA
J Ocul Pharmacol Ther; 2020; 36(6):384-392. PubMed ID: 32255727
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
[TBL] [Abstract][Full Text] [Related]
14. Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseases.
Yu W; Wu Z
Adv Drug Deliv Rev; 2021 Jan; 168():181-195. PubMed ID: 32603815
[TBL] [Abstract][Full Text] [Related]
15. Polymeric vectors for ocular gene delivery.
Tamboli V; Mishra GP; Mitrat AK
Ther Deliv; 2011 Apr; 2(4):523-36. PubMed ID: 21858246
[TBL] [Abstract][Full Text] [Related]
16. Dendrimers for gene delivery--a potential approach for ocular therapy?
Chaplot SP; Rupenthal ID
J Pharm Pharmacol; 2014 Apr; 66(4):542-56. PubMed ID: 24635556
[TBL] [Abstract][Full Text] [Related]
17. Intracellular barriers to non-viral gene transfer.
Lechardeur D; Lukacs GL
Curr Gene Ther; 2002 May; 2(2):183-94. PubMed ID: 12109215
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex viral vectors for therapeutic gene delivery to ocular tissues. Recent breakthroughs in the molecular genetics of ocular diseases.
Pepose JS; Leib DA
Invest Ophthalmol Vis Sci; 1994 May; 35(6):2662-6. PubMed ID: 8188460
[No Abstract] [Full Text] [Related]
19. Nanoparticle applications in ocular gene therapy.
Cai X; Conley S; Naash M
Vision Res; 2008 Feb; 48(3):319-24. PubMed ID: 17825344
[TBL] [Abstract][Full Text] [Related]
20. Nonviral ocular gene therapy: assessment and future directions.
Conley SM; Cai X; Naash MI
Curr Opin Mol Ther; 2008 Oct; 10(5):456-63. PubMed ID: 18830921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
